Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

Pelzer, Uwe; Schwaner, Ingo; Stieler, Jens; Adler, Mathias; Seraphin, Jörg; Dörken, Bernd; Riess, Hanno; Oettle, Helmut

Pelzer, Uwe; Schwaner, Ingo; Stieler, Jens; Adler, Mathias; Seraphin, Jörg; Dörken, Bernd; Riess, Hanno; Oettle, Helmut.

Affiliation

Pelzer U; Universitätsmedizin Berlin - Charité, Centrum für Tumormedizin, Augustenburger Platz 1, 13353 Berlin, Germany.

Eur J Cancer ; 47(11): 1676-81, 2011 Jul.

Article in En | MEDLINE | ID: mdl-21565490

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Deoxycytidine/analogs & derivatives; Fluorouracil/administration & dosage; Leucovorin/administration & dosage; Organoplatinum Compounds/administration & dosage; Pancreatic Neoplasms/drug therapy; Adult; Aged; Aged, 80 and over; Deoxycytidine/therapeutic use; Disease Progression; Female; Germany; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Treatment Outcome; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organoplatinum Compounds / Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Leucovorin / Deoxycytidine / Fluorouracil Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2011 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google